RecruitingNot Applicable

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

China200 participantsStarted 2023-04-01

Plain-language summary

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * (1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment. Exclusion Criteria: * (1) Patients with other types of lymphomas; (2) Pregnant women.

What they're measuring

PFS

Timeframe: 2 years

Trial details

NCT IDNCT05967949

SponsorThe First Affiliated Hospital with Nanjing Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-04-01

Contact for this trial

wei xu

+862568302182 xuwei10000@hotmail.com

View on ClinicalTrials.gov More PTCL trials